Maersk has opened a second pharmaceutical warehouse at its warehousing and distribution centre in Mszczonów, near Warsaw. Maersk has been operating in Central Europe since 2001, and launched the project to create this second pharmaceutical warehouse in late 2020.
The warehouse is fully compliant with EU GDP (Good Distribution Practice), GMP (Good Manufacturing Practice), ISO 9001 [QMS], ISO 12485 [Medical Devices] and ISO 22000 [HACCP]. It has around 15,000 sq m of warehouse space with an operational height of 11.5m and an approximate capacity of 24,000 pallet places. It is the first warehouse in Poland to achieve a BREEAM Excellent certificate, with photovoltaic panels installed on the roof as well as a chilled water system used to supply power to the coolers of all air handling units and fan coils. Its heat recovery installation will supply the buffer tank located in the gas boiler room and recycled heat collected in that way will be used to supply heaters in air handling units during the summer.
It is next to the S7 motorway that connects the two most populous Polish metropolitan areas – Silesia and Mazovia with Warsaw – and has easy access to the A1 and A2, two major Polish highways. It is 40km from Warsaw Chopin Airport.
Maersk state its pharma customers already using the existing warehouse are eyeing the new facility, which addresses their needs for high quality and environmental standards. Boehringer Ingelheim Poland has already expressed interest, and Bayer has announced it will extend its collaboration with Maersk and be transferring its business to the new warehouse as its first tenant.
Hristo Petkov, Global Vertical Head of Pharma at Maersk, said, “We know from our pharma customers that they expect their logistics partners to not only provide them with solutions – like warehousing and distribution – that meet their growth ambitions, but also match their environmental and sustainability targets. That, coupled with features that enhance quality control and the market knowledge of our staff, make this facility an attractive option for global pharma customers strongly present in Central Europe.”
The global Maersk Pharma team currently handles over 25,000 orders per year for more than 30 key clients transporting pharmaceutical and veterinary products, medical devices, and dangerous Pharmaceutical goods.
Source: Maersk
